News

A randomized clinical trial of patients with nonspecific subacute or chronic low back pain (LBP) concluded that standard osteopathic manipulative treatment (OMT) had minimal or no clinically meaningful positive effect on LBP-specific activity limitations compared with sham treatment.

Study points to the need for additional nursing training in treatment decision-making when it comes to pain management in elderly patients, especially those with dementia.

New research has demonstrated the importance that mind–body awareness can have in pain patients’ response to therapy.

Aduhelm, a pricey treatment meant to stall mental decline, may be a case study in everything that’s wrong with how America manages prescription drugs.

HealthDay News — For adult outpatients, use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with better pain scores and better global assessments, according to a review published online June 14 in CMAJ, the journal of the Canadian Medical Association.

Fascinating new research led by scientists from Massachusetts General Hospital has found a strong link between opioid addiction and vitamin D deficiency. The research indicates subjects with low vitamin D levels may experience heightened euphoric effects from opioids, making them more susceptible to addiction.

Treatment with the anticonvulsant agent pregabalin was superior to placebo for reducing neuropathic pain in patients with chronic spinal cord injury (SCI), while cannbinoids were ineffective, according to a study in Pain Medicine.

The lack of a gold standard to compare pain mechanism categories (PMCs) in the pain management field represents an urgent research need, and expert consensus according to a systematic review published in Pain.

New guidelines released by the World Health Organization advise for the use of physical therapy and psychological therapies alongside pharmacologic treatment to manage pediatric chronic pain, highlighting the need for a biopsychosocial approach to pain management in children.

Scientists have demonstrated that conolidine, a natural painkiller derived from the pinwheel flower and traditionally used in Chinese medicine, interacts with the newly identified opioid receptor ACKR3/CXCR7 that regulates opioid peptides naturally produced in the brain.